AU6143594A - Novel 2-phenoxy ethylamine derivatives, their preparation and their therapeutical use - Google Patents

Novel 2-phenoxy ethylamine derivatives, their preparation and their therapeutical use

Info

Publication number
AU6143594A
AU6143594A AU61435/94A AU6143594A AU6143594A AU 6143594 A AU6143594 A AU 6143594A AU 61435/94 A AU61435/94 A AU 61435/94A AU 6143594 A AU6143594 A AU 6143594A AU 6143594 A AU6143594 A AU 6143594A
Authority
AU
Australia
Prior art keywords
novel
preparation
therapeutical use
ethylamine derivatives
phenoxy ethylamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61435/94A
Other languages
English (en)
Inventor
Dennis Bigg
Bernard Bonnaud
Florence Castan
Wouter Koek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU6143594A publication Critical patent/AU6143594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU61435/94A 1993-03-04 1994-02-24 Novel 2-phenoxy ethylamine derivatives, their preparation and their therapeutical use Abandoned AU6143594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9302502 1993-03-04
FR9302502A FR2702211B1 (fr) 1993-03-04 1993-03-04 Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.
PCT/FR1994/000202 WO1994020466A1 (fr) 1993-03-04 1994-02-24 Nouveaux derives de la phenoxy-2 ethylamine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AU6143594A true AU6143594A (en) 1994-09-26

Family

ID=9444650

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61435/94A Abandoned AU6143594A (en) 1993-03-04 1994-02-24 Novel 2-phenoxy ethylamine derivatives, their preparation and their therapeutical use

Country Status (7)

Country Link
EP (1) EP0687252A1 (fr)
JP (1) JPH08507302A (fr)
AU (1) AU6143594A (fr)
CA (1) CA2152400A1 (fr)
FR (1) FR2702211B1 (fr)
WO (1) WO1994020466A1 (fr)
ZA (1) ZA941532B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA58476C2 (uk) * 1997-10-09 2003-08-15 Санофі-Сентелябо Похідні 8-азабіцикло[3.2.1]октан-3-метанаміну, фармацевтична композиція та лікарський засіб
FR2769629B1 (fr) * 1997-10-09 1999-11-12 Synthelabo Derives de 8-azabicyclo[3.2.1]octane-3-methanamine, leur preparation et leur application en therapeutique
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
FR2786767B1 (fr) * 1998-12-02 2001-02-23 Pf Medicament Nouveaux derives de 3-alkoxybenzylamines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie
FR2791676B1 (fr) * 1999-03-29 2001-06-22 Pf Medicament Nouveaux derives de [(2-substitue-5-[thienyl])-benzyl]- [2-([isopropoxy-5-fluoro]-phenoxy) ethyl]-amine, leur procede de preparation et leur utilisation a titre de medicaments
EP3260452A1 (fr) * 2016-06-24 2017-12-27 Neurolixis Composes pour le traitement des troubles sensibles à la serotonine commande par the recepteurs 5-ht1a

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658823B1 (fr) * 1990-02-27 1992-04-30 Adir Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent .
EP0522914A1 (fr) * 1991-06-27 1993-01-13 Synthelabo Dérivés de 2-pipéridinylpyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
CA2152400A1 (fr) 1994-09-15
WO1994020466A1 (fr) 1994-09-15
FR2702211A1 (fr) 1994-09-09
JPH08507302A (ja) 1996-08-06
ZA941532B (en) 1994-10-06
EP0687252A1 (fr) 1995-12-20
FR2702211B1 (fr) 1995-06-02

Similar Documents

Publication Publication Date Title
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
AU1108695A (en) Aza-4-iminoquinolines, methods of preparing them and their use
AU6124196A (en) Novel dolastatin derivatives, their preparation and use
AU9075591A (en) N-halochitosans, their preparation and uses
AU7214796A (en) Novel amino acid derivatives, their preparation and use
AU7095296A (en) Phosphorylamides, their preparation and use
AU6658596A (en) Substituted 1-phenyluracil derivatives, their preparation and their use as herbicides
AU6983494A (en) Indazolesulfonylurea derivative, use thereof, and intermediate for production thereof
AU6209790A (en) Pyridinyl-quinolone compounds, their preparation and use
AU5922694A (en) 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
AU5124390A (en) 2-halocyclopropylethane derivatives, processes for their preparation and their use as pesticides
AU4926190A (en) 2,3,23-trihydroxy-urs-12-ene and its derivatives, processes for their preparation and their use
AU6923794A (en) Piperidine derivatives, their preparation and use
AU1314995A (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
AU4509696A (en) 3-benzoylpyridine derivatives, their preparation and their use as herbicides
AU6143594A (en) Novel 2-phenoxy ethylamine derivatives, their preparation and their therapeutical use
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
AU639825B2 (en) Substituted 1,2,4-triazinediones, processes for their preparation, intermediates therefor and their use
AU6511294A (en) Tonometer
AU7244094A (en) Lavendamycin analogs, their use and preparation
AU6923994A (en) Piperidine derivatives, their preparation and use
AU6928294A (en) Thiomarinol derivatives, process and intermediates for their preparation and their use as microbicides and herbicides
AU8998391A (en) Pyrimidinyl- and triazinyl-salicylamides and their use and preparation
AU6923894A (en) 1,2,5-thiadiazole derivatives, their preparation and use